Treatment of subacute sclerosing panencephalitis with 5-bromo-2-deoxyuridine and pyran copolymer.
D001973:Bromodeoxyuridine / Q000627:therapeutic use*; D002540:Cerebral Cortex / Q000503:physiopathology; D002648:Child; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy* / Q000503:physiopathology; D004569:Electroencephalography; D004660:Encephalitis; D005260:Female; D006801:Humans; D007372:Interferons / Q000096:biosynthesis; D008297:Male; D008457:Measles; D009103:Multiple Sclerosis; D011108:Polymers; D011714:Pyrans / Q000627:therapeutic use*; D005719:gamma-Globulins / Q000134:cerebrospinal fluid
D011108:Polymers; D011714:Pyrans; D005719:gamma-Globulins; D007372:Interferons; D001973:Bromodeoxyuridine